2023-05-24T00:00:00.000+10:00
Ongoing

BX43361

BX43361
Solid tumors

A master screening Study to Determine Biomarker Status and Potential Trial Eligibility for Patients with Malignant Tumors

A master screening Study to Determine Biomarker Status and Potential Trial Eligibility for Patients with Malignant Tumors

Trial overview

Topic

Lung cancer

Trial registration

Number: NCT05419375

Study details

This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomarker status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging system.

Further information

For more information regarding this clinical trial click here.

Location

GenesisCare North Shore – PI: Nick Pavlakis

GenesisCare North Shore – PI: Nick Pavlakis :::

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.